FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2280192011> ?p ?o ?g. }

• W2280192011 endingPage "43" @default.
• W2280192011 startingPage "36" @default.
• W2280192011 abstract "To assess the efficacy and safety of K-877 (Pemafibrate), a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα) that possesses unique PPARα activity and selectivity, compared with placebo and fenofibrate in dyslipidaemic patients with high triglyceride (TG) and low high-density lipoprotein cholesterol (HDL-C) levels.This study was a double blind, placebo-controlled, parallel-group 12-week clinical trial. The study randomized 224 patients to K-877 0.025, 0.05, 0.1, 0.2 mg BID, fenofibrate 100 mg QD, or placebo (1:1:1:1:1:1) groups. Least squares mean percent changes from the baseline TG levels were -30.9%, -36.4%, -42.6%, -42.7% for the K-877 0.025, 0.05, 0.1, 0.2 mg BID respectively (p < 0.001), which were greater than that of the fenofibrate 100 mg QD (-29.7%, p < 0.001) group. Statistically significant improvements from the baseline HDL-C, very-low-density lipoprotein cholesterol, chylomicron cholesterol, remnant lipoprotein cholesterol, apolipoprotein (apo) B (apoB), and apoC-III were also observed in the K-877 groups. The incidence of adverse events (AEs) in the K-877 groups (32.4-56.8%) was comparable to those in placebo (47.2%) and fenofibrate 100 mg QD (56.8%); adverse drug reactions (ADRs) in the K-877 groups (2.7-5.4%) were less than those in placebo (8.3%) and fenofibrate 100 mg QD (10.8%) groups.In dyslipidaemic patients with high TG and low HDL-C, K-877 improved TG, HDL-C, and other lipid parameters without increasing AEs or ADRs, compared to placebo and fenofibrate. K-877 can be expected to improve atherogenicity and to be a new beneficial treatment for dyslipidaemic patients." @default.
• W2280192011 created "2016-06-24" @default.
• W2280192011 creator A5012076071 @default.
• W2280192011 creator A5014010927 @default.
• W2280192011 creator A5035876498 @default.
• W2280192011 creator A5058350680 @default.
• W2280192011 creator A5067248419 @default.
• W2280192011 creator A5076061467 @default.
• W2280192011 creator A5079640536 @default.
• W2280192011 creator A5089216722 @default.
• W2280192011 date "2016-06-01" @default.
• W2280192011 modified "2023-10-12" @default.
• W2280192011 title "Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial" @default.
• W2280192011 cites W1615613652 @default.
• W2280192011 cites W1972661406 @default.
• W2280192011 cites W1983397453 @default.
• W2280192011 cites W1994789322 @default.
• W2280192011 cites W2017342841 @default.
• W2280192011 cites W2030365295 @default.
• W2280192011 cites W2054851194 @default.
• W2280192011 cites W2071048602 @default.
• W2280192011 cites W2089035720 @default.
• W2280192011 cites W2092700213 @default.
• W2280192011 cites W2096210401 @default.
• W2280192011 cites W2108169164 @default.
• W2280192011 cites W2114056762 @default.
• W2280192011 cites W2114976556 @default.
• W2280192011 cites W2119331212 @default.
• W2280192011 cites W2143716053 @default.
• W2280192011 cites W2144259092 @default.
• W2280192011 cites W2164324917 @default.
• W2280192011 cites W2185025112 @default.
• W2280192011 cites W2198678228 @default.
• W2280192011 cites W2200285648 @default.
• W2280192011 cites W3145726055 @default.
• W2280192011 cites W4236673002 @default.
• W2280192011 doi "https://doi.org/10.1016/j.atherosclerosis.2016.02.029" @default.
• W2280192011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27062408" @default.
• W2280192011 hasPublicationYear "2016" @default.
• W2280192011 type Work @default.
• W2280192011 sameAs 2280192011 @default.
• W2280192011 citedByCount "134" @default.
• W2280192011 countsByYear W22801920112016 @default.
• W2280192011 countsByYear W22801920112017 @default.
• W2280192011 countsByYear W22801920112018 @default.
• W2280192011 countsByYear W22801920112019 @default.
• W2280192011 countsByYear W22801920112020 @default.
• W2280192011 countsByYear W22801920112021 @default.
• W2280192011 countsByYear W22801920112022 @default.
• W2280192011 countsByYear W22801920112023 @default.
• W2280192011 crossrefType "journal-article" @default.
• W2280192011 hasAuthorship W2280192011A5012076071 @default.
• W2280192011 hasAuthorship W2280192011A5014010927 @default.
• W2280192011 hasAuthorship W2280192011A5035876498 @default.
• W2280192011 hasAuthorship W2280192011A5058350680 @default.
• W2280192011 hasAuthorship W2280192011A5067248419 @default.
• W2280192011 hasAuthorship W2280192011A5076061467 @default.
• W2280192011 hasAuthorship W2280192011A5079640536 @default.
• W2280192011 hasAuthorship W2280192011A5089216722 @default.
• W2280192011 hasBestOaLocation W22801920111 @default.
• W2280192011 hasConcept C126322002 @default.
• W2280192011 hasConcept C134018914 @default.
• W2280192011 hasConcept C142724271 @default.
• W2280192011 hasConcept C197934379 @default.
• W2280192011 hasConcept C204787440 @default.
• W2280192011 hasConcept C27081682 @default.
• W2280192011 hasConcept C2776919658 @default.
• W2280192011 hasConcept C2778110834 @default.
• W2280192011 hasConcept C2778163477 @default.
• W2280192011 hasConcept C2778913445 @default.
• W2280192011 hasConcept C2780072125 @default.
• W2280192011 hasConcept C62746215 @default.
• W2280192011 hasConcept C71924100 @default.
• W2280192011 hasConcept C90924648 @default.
• W2280192011 hasConceptScore W2280192011C126322002 @default.
• W2280192011 hasConceptScore W2280192011C134018914 @default.
• W2280192011 hasConceptScore W2280192011C142724271 @default.
• W2280192011 hasConceptScore W2280192011C197934379 @default.
• W2280192011 hasConceptScore W2280192011C204787440 @default.
• W2280192011 hasConceptScore W2280192011C27081682 @default.
• W2280192011 hasConceptScore W2280192011C2776919658 @default.
• W2280192011 hasConceptScore W2280192011C2778110834 @default.
• W2280192011 hasConceptScore W2280192011C2778163477 @default.
• W2280192011 hasConceptScore W2280192011C2778913445 @default.
• W2280192011 hasConceptScore W2280192011C2780072125 @default.
• W2280192011 hasConceptScore W2280192011C62746215 @default.
• W2280192011 hasConceptScore W2280192011C71924100 @default.
• W2280192011 hasConceptScore W2280192011C90924648 @default.
• W2280192011 hasFunder F4320316238 @default.
• W2280192011 hasLocation W22801920111 @default.
• W2280192011 hasLocation W22801920112 @default.
• W2280192011 hasOpenAccess W2280192011 @default.
• W2280192011 hasPrimaryLocation W22801920111 @default.
• W2280192011 hasRelatedWork W1986416204 @default.
• W2280192011 hasRelatedWork W2004247699 @default.
• W2280192011 hasRelatedWork W2004682325 @default.
• W2280192011 hasRelatedWork W2033921535 @default.
• W2280192011 hasRelatedWork W2050189853 @default.

• next